VECTRON™ T500 VECTRON™ T500

An innovation in malaria eradication
for people and society

Making home safer

Homes should be a safe place to live.

Treating homes with VECTRON™ T500 will help prevent diseases

such a malaria and protect all who live there.

A home to grow our family and future.

Country Data

Burkina Faso

Experimental Hut Trial has been conducted in Burkina Faso to evaluate VECTRON™ T500 residual efficacy applied on both concrete and mud hut against pyrethroid susceptible Anopheles gambiae s.s. and resistant wild An. coluzzii. It provided residual efficacy (>80%) through nine months on concrete and mud substrates against susceptible, on mud substrate against resistant strain, for 8 months on concrete substrate against resistant strain.

Ghana

Village Hut Trial has been conducted in Ghana to evaluate VECTRON™ T500 residual efficacy applied on both concrete and mud hut against pyrethroid susceptible Anopheles gambiae s.s. and resistant wild An. gambiae s.l. It provided residual efficacy (>80%) through six months on cement and mud substrates. This trial will continue until 12 months after spraying.

Tanzania

Experimental Hut Trial has been conducted in Tanzania to evaluate VECTRON™ T500 residual efficacy applied on both concrete and mud hut against pyrethroid susceptible Anopheles gambiae s.s. and resistant An. gambiae s.s.Muleba-Kis. It provided residual efficacy (>80%) through seven months on concrete substrates and six months on mud. This trial will continue until 12 months after spraying.

Burkina Faso Ghana Tanzania

Click on the country

  • Registered
  • Under development

What’s New

Product image

Product

VECTRON™ T500

VECTRON™ T500 is an innovative insecticide developed for

Indoor Residual Spraying (IRS) to support

insecticide resistance management (IRM) strategies.